PMCB
PharmaCyte Biotech, Inc.
Latest Form 4:Purchase$23KbySilverman Joshua (CEO and President) · filed Jan 7, 2026
PharmaCyte Biotech, Inc. (PMCB) has 7 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jan 7, 2026.
The most active filer is CEO and President Silverman Joshua with 3 filings. Insiders have net bought $129K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Joshua N. Silverman
- Employees:2
- HQ:Las Vegas, NV, US
- IPO:2013-01-02
Insider Buying
$129K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Silverman JoshuaFirst filing | CEO and President | Purchase | 30,000 | $23K | Jan 7 | SEC ↗ |
Silverman JoshuaFirst filing | CEO and President | Purchase | 30,000 | $24K | Jan 7 | SEC ↗ |
Silverman JoshuaFirst filing | CEO and President | Purchase | 40,000 | $33K | Jan 7 | SEC ↗ |
| Director | Purchase | 20,000 | $16K | Jan 7 | SEC ↗ | |
| Director | Purchase | 20,000 | $16K | Jan 7 | SEC ↗ | |
| Director | Purchase | 20,000 | $17K | Jan 7 | SEC ↗ |
Related companies
PharmaCyte Biotech, Inc. is in the Healthcare sector.